An international team from Greenberg Traurig advised private equity fund Gilde Healthcare, a specialist healthcare investor, on the acquisition of med tech company Acti-Med AG. The parties agreed to not disclose the purchase price.
Gilde Healthcare is acquiring both Acti-Med AG, based in Hesse, and its wholly owned Polish subsidiary based in Kozerkí by way of a share deal. Founded in 1997, Acti-Med focuses on the development and production of cannulas for the medical and pharmaceutical industries.
The interdisciplinary Greenberg Traurig team from Germany and Poland comprehensively advised Gilde Healthcare on all legal aspects of the transaction.
Background: Greenberg Traurig advised Gilde Healthcare for the first time and won the client through a pitch.
About Greenberg Traurig: Greenberg Traurig, LLP (GT), has approximately 2200 attorneys in 40 locations in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. The firm is net carbon neutral with respect to its office energy usage and Mansfield Rule 3.0 Certified. Web: www.gtlaw.com
Gilde Healthcare is acquiring both Acti-Med AG, based in Hesse, and its wholly owned Polish subsidiary based in Kozerkí by way of a share deal. Founded in 1997, Acti-Med focuses on the development and production of cannulas for the medical and pharmaceutical industries.
The interdisciplinary Greenberg Traurig team from Germany and Poland comprehensively advised Gilde Healthcare on all legal aspects of the transaction.
Background: Greenberg Traurig advised Gilde Healthcare for the first time and won the client through a pitch.